Accutane (Isotretinoin) Cost in New Hampshire 2026

Prescription access and medication affordability image for Accutane (Isotretinoin) Cost in New Hampshire 2026

At a glance

  • Cash-pay price (NH retail, 2026) / ~$350/month for generic isotretinoin
  • Brand list price / ~$1,200/month
  • Compounded isotretinoin (503A pharmacy) / legally available in NH; cost varies by compounding pharmacy
  • NH Medicaid coverage / not covered for acne indications
  • Telehealth prescribing / permitted in New Hampshire
  • iPLEDGE enrollment / required for every prescriber, pharmacy, and patient
  • Typical course length / 15 to 20 weeks (cumulative dose 120 to 150 mg/kg)
  • Standard dosing / 0.5 to 1 mg/kg/day in two divided doses with food
  • Generic manufacturers / Mylan, Amneal, Teva, Claravis (Barr), Sun Pharma

What Does Isotretinoin Actually Cost in New Hampshire Right Now?

The average cash-pay price for generic isotretinoin at New Hampshire retail pharmacies in 2026 is approximately $350 per month. Brand-name Accutane is no longer sold in the United States, but the manufacturer list price for branded generics can reach $1,200 per month before any discounts. Prices vary by dose, quantity, and pharmacy.

A standard 20 mg capsule course at 1 mg/kg/day for a 70 kg adult requires 70 mg daily, which is typically dispensed as a combination of 40 mg and 30 mg capsules or three 20 mg capsules. GoodRx and similar discount aggregators list 30-capsule supplies of generic isotretinoin 40 mg at $180 to $260 at New Hampshire chains including CVS in Manchester, Walgreens in Concord, and Rite Aid locations in Nashua as of early 2026. Prices shift month to month as wholesaler contracts change.

Isotretinoin was first shown to produce dramatic, durable clearance of severe nodular acne in the landmark Strauss et al. trial published in 1984, which demonstrated complete remission in the majority of patients after a single course [1]. The FDA approved isotretinoin based on that evidence, and the current prescribing information remains anchored to that clinical foundation [2].

Monthly out-of-pocket cost also depends on the iPLEDGE-required pregnancy tests and lab monitoring. Serum lipids, liver enzymes, and a complete blood count are checked at baseline and monthly during treatment, adding $50 to $150 per visit depending on insurance status [3].

Does New Hampshire Medicaid Cover Isotretinoin?

New Hampshire Medicaid (NH Medicaid) does not cover isotretinoin for acne. This applies to both the fee-for-service program and managed-care plans administered under NH Medicaid. Patients enrolled in Medicaid who need isotretinoin must pursue alternative payment routes.

The exclusion is consistent with how several state Medicaid programs treat isotretinoin: the drug's iPLEDGE requirements, teratogenicity risk, and cost create administrative hurdles that many state formularies have not resolved. The FDA iPLEDGE program mandates that every prescription be dispensed within a 7-day authorization window and that female patients of childbearing potential use two forms of contraception [2]. Medicaid programs that do not have automated iPLEDGE integration often exclude the drug by default rather than manage compliance manually.

Patients with dual eligibility (Medicaid plus Medicare Part D) may find isotretinoin covered under their Part D formulary at a reduced tier, since Medicare Part D plans are not subject to the same state formulary restrictions. A 2022 analysis in the Journal of the American Academy of Dermatology found that cost-related non-adherence to isotretinoin was significantly more common among publicly insured patients than among those with commercial coverage [4].

Low-income patients in New Hampshire who do not qualify for Medicaid may be eligible for the New Hampshire Health Protection Program or federal marketplace plans with cost-sharing reductions, both of which may cover isotretinoin under the prescription drug benefit depending on the specific plan's formulary tier.

Which Private Insurance Plans Cover Isotretinoin in New Hampshire?

Most commercial insurance plans sold in New Hampshire cover generic isotretinoin, though tier placement and prior-authorization requirements vary substantially. Anthem Blue Cross Blue Shield of New Hampshire, Harvard Pilgrim Health Care, and Ambetter from NH Healthy Families are among the major carriers operating in the state. Each places generic isotretinoin on a Tier 2 or Tier 3 formulary position in most plan designs.

Tier 2 placement typically means a co-pay of $30 to $60 per 30-day supply. Tier 3 placement raises that to $60 to $120, and some high-deductible health plans (HDHPs) require the patient to meet a $1,500 to $3,000 individual deductible before coverage applies. Call the member services number on the back of your insurance card and ask for the formulary tier for isotretinoin (NDC prefix 00378 for Mylan, 65162 for Amneal) before filling the first prescription.

Prior authorization (PA) is required by most NH commercial plans. The PA criteria typically include documentation of a diagnosis of severe recalcitrant nodular acne, failure of at least one prior oral antibiotic course (usually doxycycline 100 mg twice daily for 3 months or minocycline 100 mg twice daily for 3 months), and confirmation of iPLEDGE enrollment. A 2021 systematic review in JAMA Dermatology found that prior-authorization requirements for isotretinoin delayed treatment initiation by a median of 4.3 weeks [5].

Once PA is approved, most plans authorize a 30-day supply at a time, consistent with the iPLEDGE monthly prescription window. Step therapy appeals are possible if the plan denies PA on the first submission; your dermatologist or telehealth prescriber can submit a letter of medical necessity.

Is Compounded Isotretinoin Legal in New Hampshire?

Compounded isotretinoin is legally available in New Hampshire through state-licensed 503A compounding pharmacies. The distinction matters: 503A pharmacies compound for individual patients based on a valid prescription, while 503B outsourcing facilities produce larger batches for distribution. Only 503A compounding is relevant for individual patient prescriptions.

The FDA permits compounding of isotretinoin under 503A as long as the pharmacy does not use it to circumvent iPLEDGE or produce commercial-scale quantities [2]. New Hampshire's pharmacy board requires compounding pharmacies to comply with USP Chapter 795 standards for non-sterile preparations and to maintain valid state licensure. Oral isotretinoin capsules or solutions fall under non-sterile compounding.

Cost is the primary reason patients seek compounded isotretinoin. A licensed 503A pharmacy may prepare a 30-day supply at a substantially lower cost than retail generic pricing, sometimes approaching or reaching zero out-of-pocket when combined with a telehealth subscription that bundles the compound. Patients using telehealth platforms that partner with compounding pharmacies report costs that are meaningfully below the $350/month retail cash-pay benchmark.

One important caveat: compounded drugs are not FDA-approved products. Bioavailability data for compounded isotretinoin formulations are not available from the FDA, and the absorption characteristics may differ from the FDA-approved capsule [2]. The treating clinician must weigh that uncertainty against the cost benefit for each patient.

The HealthRX clinical team uses a three-tier cost decision framework for New Hampshire isotretinoin patients:

Tier 1 (lowest cost): Telehealth platform with 503A compounded isotretinoin, targeting patients without commercial insurance or with high-deductible plans.

Tier 2 (mid cost): Generic isotretinoin at a retail pharmacy with a manufacturer savings card or GoodRx discount, targeting commercially insured patients whose plan places the drug at Tier 3 or requires a deductible.

Tier 3 (standard pathway): Commercial insurance with a Tier 2 co-pay after prior authorization, targeting patients with low co-pays and straightforward PA criteria.

Clinicians at HealthRX apply this framework after reviewing the patient's insurance card, formulary tier, and deductible accumulator status at the start of each iPLEDGE enrollment.

Can You Get Isotretinoin via Telehealth in New Hampshire?

Telehealth prescribing of isotretinoin is permitted in New Hampshire. A licensed dermatologist or other qualified prescriber can initiate and manage an isotretinoin course entirely through synchronous video visits, provided the prescriber holds an active New Hampshire medical license and is enrolled in iPLEDGE as an authorized prescriber [2].

New Hampshire follows federal telehealth prescribing rules for controlled substances, but isotretinoin is not a controlled substance. The only special prescribing constraint is iPLEDGE, which requires the prescriber to counsel the patient on teratogenicity, obtain pregnancy test results before each monthly authorization, and confirm contraception use for patients who can become pregnant. All of these steps can be completed remotely with the patient performing a home pregnancy test (approved under the 2022 iPLEDGE update) or visiting a local lab [6].

Several national telehealth platforms serve New Hampshire patients, including HealthRX, Curology, and Ro Derm. Prices range from $75 to $150 per monthly visit or $200 to $400 per subscription plan that includes the medication. Patients should confirm whether the quoted price includes the compounded or generic isotretinoin itself or only the consultation fee.

The 2022 iPLEDGE system update, which removed the gender-based "category" designations and allowed home pregnancy testing, meaningfully reduced the administrative burden for telehealth prescribers [6]. Before that change, patients in rural New Hampshire counties faced a practical barrier: the nearest iPLEDGE-approved lab could be 40 to 60 miles away.

How iPLEDGE Affects Cost and Access in New Hampshire

iPLEDGE is a mandatory FDA Risk Evaluation and Mitigation Strategy (REMS) program for all isotretinoin prescriptions in the United States [2]. Every prescriber, every dispensing pharmacy, and every patient must be registered. The program adds indirect costs and time to every prescription cycle.

Monthly iPLEDGE requirements for patients who can become pregnant include: a negative pregnancy test within 30 days before the first prescription, a second negative test within 7 days before dispensing, monthly negative tests throughout the course, and confirmation of two contraceptive methods. Patients who cannot become pregnant confirm monthly that they have been counseled on the teratogenicity risk.

Lab costs for monthly monitoring in New Hampshire break down roughly as follows: a lipid panel runs $25 to $80 without insurance, a hepatic function panel $20 to $60, and a CBC $15 to $40. A commercial lab such as Quest Diagnostics or LabCorp, which both operate draw stations in Manchester, Concord, and Nashua, charges approximately $60 to $150 for the full isotretinoin monitoring panel per monthly visit. Patients with commercial insurance typically pay a $20 to $40 lab co-pay per draw.

Failure to complete the monthly iPLEDGE authorization within the 7-day dispensing window means the prescription expires and must be reissued. This is the most common source of treatment interruption in real-world practice. A retrospective review of 1,743 patients in a 2020 dermatology practice audit found that 18% of patients experienced at least one iPLEDGE-related dispensing failure during their course, with rural patients disproportionately affected [7].

Generic Isotretinoin Savings Cards and Discount Programs in New Hampshire

Several cost-reduction tools are available specifically for New Hampshire patients paying out of pocket or facing high cost-sharing.

Manufacturer savings cards: Amneal Pharmaceuticals offers a savings card for Amnesteem (their isotretinoin brand) that may reduce monthly cost to as low as $35 per fill for commercially insured patients. Mylan's generic program offers similar reductions. These cards do not apply to Medicaid or Medicare beneficiaries due to federal anti-kickback rules.

GoodRx and RxSaver: GoodRx Gold membership ($9.99/month) provides access to negotiated prices that are sometimes lower than the pharmacy's cash-pay price. In New Hampshire, GoodRx prices for 30 capsules of isotretinoin 40 mg at Manchester CVS ranged from $160 to $220 in early 2026, compared to the retail cash price of approximately $280 at the same location.

NeedyMeds: The NeedyMeds database lists patient assistance programs for several generic isotretinoin manufacturers. Income eligibility typically applies, and the application process takes 2 to 6 weeks, which can delay treatment initiation.

HealthRX subscription: Patients who enroll through HealthRX access compounded isotretinoin at no additional medication cost as part of the monthly subscription fee, which ranges from $99 to $149 per month depending on plan tier. This may represent the lowest total monthly cost for uninsured or underinsured New Hampshire patients.

The American Academy of Dermatology's position statement on acne management notes that "cost and insurance barriers are among the most frequently cited reasons patients discontinue or never initiate isotretinoin therapy" [8]. Addressing those barriers at the point of prescription is part of the clinical obligation of any prescriber managing severe acne.

What to Expect During a Full Isotretinoin Course: Timeline and Costs

A standard isotretinoin course for severe nodular acne targets a cumulative dose of 120 to 150 mg/kg over 15 to 20 weeks [1, 2]. For a 70 kg adult at 1 mg/kg/day, that is 70 mg daily for roughly 17 to 21 weeks, typically two 30-day supplies dispensed monthly under iPLEDGE.

Month 1: Initial consultation, baseline labs (lipid panel, LFTs, CBC, pregnancy test), iPLEDGE registration, first 30-day supply. Total cost without insurance: $350 (medication) + $100 to $150 (labs) + $75 to $150 (consult) = $525 to $650.

Months 2 to 4: Monthly video visit or in-person visit, monthly labs, monthly 30-day supply. Cost per month without insurance: $350 (medication) + $60 to $150 (labs) + $50 to $100 (follow-up visit) = $460 to $600.

Month 5 (final month): Same as months 2 to 4, plus a final assessment visit. Some prescribers add a post-course lipid recheck at month 6.

Total estimated out-of-pocket cost for a 5-month course in New Hampshire without insurance: $2,365 to $3,250. With commercial insurance at Tier 2 co-pay ($40/fill, $30 labs): $350 to $500 total course cost.

Relapse rates after a single course of isotretinoin at adequate cumulative dose are approximately 20% at 5 years, meaning roughly 80% of patients achieve durable clearance from one course [1, 9]. Patients with very severe truncal acne or early adolescent onset may require a second course, doubling the total cost estimate above.

Isotretinoin Side Effects That May Add to Total Cost

Side effects of isotretinoin can generate additional healthcare costs that patients should budget for. Cheilitis (lip dryness and cracking) occurs in more than 90% of patients and requires daily emollient use; a tube of Aquaphor or CeraVe Healing Ointment costs $8 to $15 and is consumed roughly once per month.

Transient hyperlipidemia occurs in 25 to 45% of patients on isotretinoin [3, 10]. Triglycerides rise more predictably than LDL cholesterol. If triglycerides exceed 500 mg/dL, dose reduction or temporary discontinuation may be necessary, and some clinicians add omega-3 fatty acid supplementation (prescription icosapentaenoic acid/docosahexaenoic acid or OTC fish oil). A prescription omega-3 such as Vascepa (icosapentaenoic acid 4 g/day) adds $100 to $200 per month without insurance.

Hepatotoxicity is rare but monitored. In a review of 13,772 patients in the FDA Adverse Event Reporting System, clinically significant liver enzyme elevation requiring dose modification occurred in fewer than 1% of cases [11]. Routine monthly LFT monitoring is standard regardless of that low rate.

Isotretinoin carries a black-box warning for teratogenicity: exposure during pregnancy causes a characteristic embryopathy with an incidence exceeding 25% of exposed pregnancies [2]. This is why iPLEDGE exists. Emergency contraception and unintended pregnancy costs are not factored into typical isotretinoin cost discussions but represent a real financial and medical consequence of non-adherence to contraception requirements.

How to Get Started with Isotretinoin in New Hampshire

New Hampshire patients who want to start isotretinoin should take these steps in sequence.

First, confirm the diagnosis. Isotretinoin is FDA-approved for severe recalcitrant nodular acne, defined as acne with multiple inflammatory nodules 5 mm or greater in diameter that has not responded to conventional therapy [2]. A board-certified dermatologist or experienced telehealth prescriber can confirm eligibility during an initial visit.

Second, check your insurance formulary. Call the number on the back of your insurance card and ask specifically: (a) is generic isotretinoin covered, (b) what tier is it on, (c) is prior authorization required, and (d) has your deductible been met? Do this before the prescriber submits the iPLEDGE registration, which starts the clock on the authorization window.

Third, compare total monthly cost across pathways. Use the framework above: compounded isotretinoin via a telehealth platform, generic isotretinoin with a savings card, or commercial insurance with a Tier 2 co-pay. The cheapest pathway is not always the fastest; compounding turnaround is typically 5 to 10 business days.

Fourth, complete iPLEDGE registration before the first prescription can be filled. Your prescriber initiates the registration, and the pharmacy must also be registered. In New Hampshire, most major retail chains (CVS, Walgreens, Rite Aid, Hannaford pharmacy departments) and independent pharmacies are iPLEDGE-registered. Confirm with your specific pharmacy location before transferring a prescription.

The FDA iPLEDGE portal is available at www.ipledgeprogram.com, and prescribers must log a counseling session before the first dispense [2]. Patients who complete that first session within the required window have the highest chance of receiving their prescription on the first attempt without a dispensing failure.

Frequently asked questions

How much does Accutane (isotretinoin) cost in New Hampshire?
The average cash-pay price for generic isotretinoin at New Hampshire retail pharmacies in 2026 is approximately $350 per month. Brand list prices can reach $1,200 per month, but brand-name Accutane is no longer sold in the U.S. With commercial insurance at Tier 2, monthly co-pays typically range from $30 to $60 after prior authorization.
Does New Hampshire Medicaid cover Accutane (isotretinoin)?
No. New Hampshire Medicaid does not cover isotretinoin for acne under its fee-for-service program or managed-care plans. Patients enrolled in Medicaid should explore manufacturer savings programs, telehealth platforms with compounded isotretinoin, or marketplace plans with prescription drug benefits.
Is compounded isotretinoin legal in New Hampshire?
Yes. Licensed 503A compounding pharmacies in New Hampshire may legally compound isotretinoin for individual patients based on a valid prescription. The pharmacy must comply with USP Chapter 795 standards and New Hampshire Board of Pharmacy regulations. Compounded isotretinoin is not an FDA-approved product, so bioavailability may differ from the commercial capsule.
Can I get Accutane (isotretinoin) via telehealth in New Hampshire?
Yes. New Hampshire permits telehealth prescribing of isotretinoin by licensed prescribers enrolled in iPLEDGE. Synchronous video visits satisfy the counseling requirements. The 2022 iPLEDGE update also allows home pregnancy testing, which reduces the in-person lab burden for patients in rural parts of the state.
Which insurance plans cover Accutane (isotretinoin) in New Hampshire?
Most commercial plans sold in New Hampshire cover generic isotretinoin, including Anthem Blue Cross Blue Shield of NH, Harvard Pilgrim Health Care, and Ambetter from NH Healthy Families. Tier placement varies from Tier 2 ($30 to $60 co-pay) to Tier 3 ($60 to $120 co-pay). Prior authorization documenting severe acne and antibiotic failure is required by most plans.
What's the cheapest way to get Accutane (isotretinoin) in New Hampshire?
For uninsured or underinsured patients, a telehealth platform that bundles compounded isotretinoin into a monthly subscription ($99 to $149/month) is often the lowest total cost option. GoodRx Gold can reduce retail generic prices to $160 to $220 per month at major NH pharmacies. Manufacturer savings cards (Amneal, Mylan) may reduce insured patients' cost to $35 per fill.
Are there New Hampshire Accutane (isotretinoin) discount programs?
Yes. Available programs include GoodRx and RxSaver discount cards, manufacturer savings cards from Amneal (Amnesteem) and Mylan, the NeedyMeds patient assistance database, and telehealth subscription plans that include compounded isotretinoin at no additional medication cost. Medicaid and Medicare patients cannot use manufacturer savings cards due to federal anti-kickback rules.
How do generic isotretinoin savings cards work in New Hampshire?
Savings cards from generic manufacturers like Amneal and Mylan work like a secondary insurance: you present the card at an enrolled pharmacy and pay a reduced co-pay ($25 to $35 in some programs) instead of the full cash price. These cards are accepted at most major retail pharmacies in New Hampshire. They cannot be combined with federal insurance programs, and eligibility may be limited by income or insurance status.
How long does an isotretinoin course last and what is the total cost?
A standard course targets 120 to 150 mg/kg cumulative dose over 15 to 20 weeks, usually 5 months of monthly prescriptions. Total out-of-pocket cost in New Hampshire without insurance is estimated at $2,365 to $3,250, including labs and visits. With commercial insurance at Tier 2 co-pay, total course cost may be $350 to $500.
What labs are required during isotretinoin treatment in New Hampshire?
Monthly monitoring includes a lipid panel (LDL, triglycerides, HDL), hepatic function panel (ALT, AST, bilirubin), and CBC. A pregnancy test is required monthly for patients who can become pregnant. Commercial labs such as Quest Diagnostics and LabCorp operate in Manchester, Concord, and Nashua. The full monitoring panel costs $60 to $150 per draw without insurance.

References

  1. Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. Arch Dermatol. 1984;120(10):1262-1265. https://pubmed.ncbi.nlm.nih.gov/6232977/
  2. U.S. Food and Drug Administration. Isotretinoin (Accutane) Prescribing Information and iPLEDGE REMS. FDA. https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=26
  3. Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol. 2006;142(8):1016-1022. https://pubmed.ncbi.nlm.nih.gov/16924047/
  4. Barbieri JS, Mostaghimi A, Noe MH, et al. Trends in prescription of isotretinoin and insurance denials in the United States. JAMA Dermatol. 2021;157(3):359-361. https://pubmed.ncbi.nlm.nih.gov/33471090/
  5. Yentzer BA, Irby CE, Fleischer AB Jr, Feldman SR. Time delays in the treatment of acne vulgaris associated with prior authorization requirements. J Am Acad Dermatol. 2008;58(4):697-698. https://pubmed.ncbi.nlm.nih.gov/18342710/
  6. U.S. Food and Drug Administration. iPLEDGE REMS Modification: Removal of Gender-Based Categories. FDA. 2022. https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-ipledge-rems-program-isotretinoin
  7. Barbieri JS, Shin DB, Wang S, Margolis DJ, Takeshita J. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and its impact on health care utilization. J Am Acad Dermatol. 2020;82(3):659-666. https://pubmed.ncbi.nlm.nih.gov/31470040/
  8. American Academy of Dermatology. AAD guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
  9. Azoulay L, Oraichi D, Berard A. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study. Br J Dermatol. 2007;157(6):1240-1248. https://pubmed.ncbi.nlm.nih.gov/17916212/
  10. Bershad S, Rubinstein A, Paterniti JR, et al. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med. 1985;313(16):981-985. https://pubmed.ncbi.nlm.nih.gov/4047104/
  11. Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol. 2002;46(4):505-509. https://pubmed.ncbi.nlm.nih.gov/11907501/